We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Immune Deficiency Due to Defective DNA Repair

By Biotechdaily staff writers
Posted on 22 May 2002
A mutation in a gene whose product is responsible for repair of damaged DNA molecules is the underlying cause of a form of severe immunodeficiency. More...
This finding is reported in a study published in the March 22, 2002, issue of Cell.

The gene was first described in April of 2001 by a team of French researchers who named it and its product Artemis (after the Greek goddess for the protection of children). However, they did not report what kind of protein it was nor what its function might be.

Now, Dr. Michael Lieber from the Keck School of Medicine at the University of Southern California (Los Angeles CA, USA) and his colleagues from the University of Ulm (Germany; www.uni-ulm.de) have conclusively demonstrated that Artemis is a key protein in the repair of damage to double-stranded DNA, a process called NHEJ (nonhomologous DNA end joining). In the NHEJ pathway, the ends of the broken DNA strands are trimmed and rejoined to one another. "What Artemis does is trim away the damaged parts of the DNA so that the strands can be joined,” said Lieber.

Artemis and the NHEJ pathway are so essential that mice lacking NHEJ usually die at birth. Those that survive generally lack an immune system entirely and experience accelerated aging. Humans with a defective Artemis protein suffer from practically nonfunctional immune systems. "That is because the immune system creates its defenses by cutting and then rejoining bits of nuclear DNA (the rejoining relies on NHEJ),” says Lieber. "Without Artemis, the cells cannot create the antibodies necessary to go after the myriad pathogenic invaders we regularly encounter.”

For normal cells, Artemis and the NHEJ pathway are absolutely critical for survival. Lieber explains this is because of the extreme vulnerability of our cells to DNA damage. "Indeed,” he said, "all you have to do is take some cells out of the organism in which they live and look at them under a microscope, and you will find that 5-10% of them will have at least one broken chromosome.”




Related Links:
USC, Keck School of Medicine
University of Ulm

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
HPV Test
Allplex HPV28 Detection
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.